Source:http://linkedlifedata.com/resource/pubmed/id/12519559
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2003-1-9
|
pubmed:abstractText |
Chronic Obstructive Pulmonary Disease (COPD) is a chronic condition characterised by progressive airflow limitation that is at most partially reversible. Despite the lack of reversibility patients often report symptomatic improvement with short-acting beta-2 bronchodilator medication. Short-acting beta-2 bronchodilators are used in the management of both stable and acute exacerbations of COPD.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1469-493X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
CD001495
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12519559-Administration, Inhalation,
pubmed-meshheading:12519559-Adrenergic beta-Agonists,
pubmed-meshheading:12519559-Adult,
pubmed-meshheading:12519559-Albuterol,
pubmed-meshheading:12519559-Bronchodilator Agents,
pubmed-meshheading:12519559-Humans,
pubmed-meshheading:12519559-Lung Diseases, Obstructive,
pubmed-meshheading:12519559-Randomized Controlled Trials as Topic,
pubmed-meshheading:12519559-Terbutaline
|
pubmed:year |
2002
|
pubmed:articleTitle |
Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease.
|
pubmed:affiliation |
Institute of Respiratory Diseases, University of Siena, Viale Bracci 3, 53100, Siena, Italy. sestini@unisi.it
|
pubmed:publicationType |
Journal Article,
Review,
Meta-Analysis
|